Post Test and Evaluation

Please note that to receive credit you must achieve a score of at least 70%.
Credit will be uploaded to CPE Monitor within 4 weeks of successful completion of the activity.

Post-Activity Test

Question Title

1. The therapeutic target of epoprostenal is within the:

Endothelin pathway

Prostacyclin pathway

Glutathione pathway

Nitric oxide pathway

Question Title

2. Which of the following PAH medications is not available in oral formulation?

Treprostinil

Bosentan

Macitentan

Epoprostenol

Question Title

3. The use of nitrates is contraindicated in patients receiving a phosphodiesterase type 5 (PDE-5) inhibitor.

True

False

Question Title

4. Pulmonary arterial hypertension is defined as having a mean pulmonary arterial pressure (mPAP) of:

>10 mmHg

>25 mmHg

>40 mmHg

>60 mmHg

Question Title

5. Current PAH therapy targets all of the following pathways except:

Vasoactive intestinal peptide (VIP)

Endothelin

Nitric Oxide

Prostacyclin